论文部分内容阅读
目的探讨糖化血红蛋白检测在糖尿病微血管病变中的应用价值。方法分为微血管病变组102例,无微血管病变组196例;并选取同期进行健康体检正常组150例。对3组患者均进行空腹血糖(FBG)、糖化血红蛋白(HbA1c)检测并比较。结果微血管病变组与无微血管病变组进行FBG、HbA1c比较P<0.05有统计学意义。微血管病变组、无微血管病变组与健康体检组进行FBG、HbA1c比较P<0.05有统计学意义。结论 HbAle升高,其发生糖尿病性微血管病变的风险明显增加,糖化血红蛋白检测在糖尿病微血管病变中有着良好的指导作用[5],能够及早的发现发生微血管病变的指导性指标。
Objective To investigate the value of detecting glycated hemoglobin in diabetic microangiopathy. Methods There were 102 cases of microvascular disease group and 196 cases of non-microvascular disease group. 150 cases of normal control group were selected in the same period. Fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c) were detected and compared in all three groups. Results The microangiopathy group and no microvascular disease group FBG, HbA1c comparison P <0.05 was statistically significant. Microvascular disease group, non-microvascular disease group and healthy group were FBG, HbA1c comparison P <0.05 was statistically significant. Conclusions HbAle is increased, and the risk of developing diabetic microangiopathy is significantly increased. HbA1c has a good guiding role in the pathogenesis of diabetic microangiopathy [5], and the early detection of microvascular disease can be found.